These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23872097)

  • 1. Human stem cell osteoblastogenesis mediated by novel glycogen synthase kinase 3 inhibitors induces bone formation and a unique bone turnover biomarker profile in rats.
    Gilmour PS; O'Shea PJ; Fagura M; Pilling JE; Sanganee H; Wada H; Courtney PF; Kavanagh S; Hall PA; Escott KJ
    Toxicol Appl Pharmacol; 2013 Oct; 272(2):399-407. PubMed ID: 23872097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orally bioavailable GSK-3alpha/beta dual inhibitor increases markers of cellular differentiation in vitro and bone mass in vivo.
    Kulkarni NH; Onyia JE; Zeng Q; Tian X; Liu M; Halladay DL; Frolik CA; Engler T; Wei T; Kriauciunas A; Martin TJ; Sato M; Bryant HU; Ma YL
    J Bone Miner Res; 2006 Jun; 21(6):910-20. PubMed ID: 16753022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GSK-3 inhibition by an orally active small molecule increases bone mass in rats.
    Marsell R; Sisask G; Nilsson Y; Sundgren-Andersson AK; Andersson U; Larsson S; Nilsson O; Ljunggren O; Jonsson KB
    Bone; 2012 Mar; 50(3):619-27. PubMed ID: 22142634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of glycogen synthase kinase-3beta attenuates glucocorticoid-induced bone loss.
    Wang FS; Ko JY; Weng LH; Yeh DW; Ke HJ; Wu SL
    Life Sci; 2009 Nov; 85(19-20):685-92. PubMed ID: 19782693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in osteoblast, chondrocyte, and adipocyte lineages mediate the bone anabolic actions of PTH and small molecule GSK-3 inhibitor.
    Kulkarni NH; Wei T; Kumar A; Dow ER; Stewart TR; Shou J; N'cho M; Sterchi DL; Gitter BD; Higgs RE; Halladay DL; Engler TA; Martin TJ; Bryant HU; Ma YL; Onyia JE
    J Cell Biochem; 2007 Dec; 102(6):1504-18. PubMed ID: 17520664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel flavonoid C-glucoside from Ulmus wallichiana preserves bone mineral density, microarchitecture and biomechanical properties in the presence of glucocorticoid by promoting osteoblast survival: a comparative study with human parathyroid hormone.
    Khan MP; Mishra JS; Sharan K; Yadav M; Singh AK; Srivastava A; Kumar S; Bhaduaria S; Maurya R; Sanyal S; Chattopadhyay N
    Phytomedicine; 2013 Nov; 20(14):1256-66. PubMed ID: 23928508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycogen synthase kinase-3α/β inhibition promotes in vivo amplification of endogenous mesenchymal progenitors with osteogenic and adipogenic potential and their differentiation to the osteogenic lineage.
    Gambardella A; Nagaraju CK; O'Shea PJ; Mohanty ST; Kottam L; Pilling J; Sullivan M; Djerbi M; Koopmann W; Croucher PI; Bellantuono I
    J Bone Miner Res; 2011 Apr; 26(4):811-21. PubMed ID: 20939016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The beneficial effect of icaritin on osteoporotic bone is dependent on the treatment initiation timing in adult ovariectomized rats.
    Peng S; Zhang G; Zhang BT; Guo B; He Y; Bakker AJ; Pan X; Zhen W; Hung L; Qin L; Leung WN
    Bone; 2013 Jul; 55(1):230-40. PubMed ID: 23486180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rats treated with AZD2858, a GSK3 inhibitor, heal fractures rapidly without endochondral bone formation.
    Sisask G; Marsell R; Sundgren-Andersson A; Larsson S; Nilsson O; Ljunggren O; Jonsson KB
    Bone; 2013 May; 54(1):126-32. PubMed ID: 23337038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suberoylanilide hydroxamic acid (SAHA; vorinostat) causes bone loss by inhibiting immature osteoblasts.
    McGee-Lawrence ME; McCleary-Wheeler AL; Secreto FJ; Razidlo DF; Zhang M; Stensgard BA; Li X; Stein GS; Lian JB; Westendorf JJ
    Bone; 2011 May; 48(5):1117-26. PubMed ID: 21255693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.
    Sampath TK; Simic P; Sendak R; Draca N; Bowe AE; O'Brien S; Schiavi SC; McPherson JM; Vukicevic S
    J Bone Miner Res; 2007 Jun; 22(6):849-59. PubMed ID: 17352644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strontium ranelate rebalances bone marrow adipogenesis and osteoblastogenesis in senescent osteopenic mice through NFATc/Maf and Wnt signaling.
    Saidak Z; Haÿ E; Marty C; Barbara A; Marie PJ
    Aging Cell; 2012 Jun; 11(3):467-74. PubMed ID: 22321691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceleration of bone regeneration by local application of lithium: Wnt signal-mediated osteoblastogenesis and Wnt signal-independent suppression of osteoclastogenesis.
    Arioka M; Takahashi-Yanaga F; Sasaki M; Yoshihara T; Morimoto S; Hirata M; Mori Y; Sasaguri T
    Biochem Pharmacol; 2014 Aug; 90(4):397-405. PubMed ID: 24955980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel quercetin analogue from a medicinal plant promotes peak bone mass achievement and bone healing after injury and exerts an anabolic effect on osteoporotic bone: the role of aryl hydrocarbon receptor as a mediator of osteogenic action.
    Sharan K; Mishra JS; Swarnkar G; Siddiqui JA; Khan K; Kumari R; Rawat P; Maurya R; Sanyal S; Chattopadhyay N
    J Bone Miner Res; 2011 Sep; 26(9):2096-111. PubMed ID: 21638315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of bone formation in the expanding premaxillary suture with a GSK-3β inhibitor.
    Jiang Y; Liu HX; Guo JJ; Tang GH; Qian YF
    Oral Dis; 2013 Jan; 19(1):73-9. PubMed ID: 22776263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The peroxisome proliferator activator receptor alpha/delta agonists linoleic acid and bezafibrate upregulate osteoblast differentiation and induce periosteal bone formation in vivo.
    Still K; Grabowski P; Mackie I; Perry M; Bishop N
    Calcif Tissue Int; 2008 Oct; 83(4):285-92. PubMed ID: 18836674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The osteoprotective effect of psoralen in ovariectomy-induced osteoporotic rats via stimulating the osteoblastic differentiation from bone mesenchymal stem cells.
    Yang Z; Huang JH; Liu SF; Zhao YJ; Shen ZY; Wang YJ; Bian Q
    Menopause; 2012 Oct; 19(10):1156-64. PubMed ID: 22781784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuated Wnt/β-catenin signalling mediates methotrexate chemotherapy-induced bone loss and marrow adiposity in rats.
    Georgiou KR; King TJ; Scherer MA; Zhou H; Foster BK; Xian CJ
    Bone; 2012 Jun; 50(6):1223-33. PubMed ID: 22484100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermittent parathyroid hormone (PTH) treatment and age-dependent effects on rat cancellous bone and mineral metabolism.
    Friedl G; Turner RT; Evans GL; Dobnig H
    J Orthop Res; 2007 Nov; 25(11):1454-64. PubMed ID: 17557320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells.
    Bäckesjö CM; Li Y; Lindgren U; Haldosén LA
    J Bone Miner Res; 2006 Jul; 21(7):993-1002. PubMed ID: 16813520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.